Edwards Lifesciences Corp (EW) Com Stk USD1

Sell:$71.32Buy:$71.33$0.01 (0.01%)

Prices delayed by at least 15 minutes
Sell:$71.32
Buy:$71.33
Change:$0.01 (0.01%)
Deal now
Prices delayed by at least 15 minutes
Sell:$71.32
Buy:$71.33
Change:$0.01 (0.01%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Edwards Lifesciences Corporation is a global structural heart innovation company. The Company is engaged in patient-focused medical innovations for structural heart disease and invests in research and development to transform care for those impacted by structural heart disease. Its products are categorized into groups, including Transcatheter Aortic Valve Replacement (TAVR), Transcatheter Mitral and Tricuspid Therapies (TMTT), and Surgical Structural Heart (Surgical). It develops transcatheter heart valve replacement technologies designed for the minimally invasive replacement of aortic heart valves. The Edwards SAPIEN family of valves includes the Edwards SAPIEN 3, the Edwards SAPIEN 3 Ultra, and the Edwards SAPIEN 3 Ultra RESILIA systems, are catheter-based approaches for treating severe symptomatic aortic stenosis. Its PASCAL PRECISION and Cardioband transcatheter valve repair systems are commercially available in Europe for mitral and tricuspid valve repair.

Key people

Bernard J. Zovighian
President, Chief Executive Officer
Scott B. Ullem
Chief Financial Officer, Corporate Vice President
Wayne Markowitz
Senior Vice President, General Manager - Surgical Structural Heart
Donald E. Bobo
Corporate Vice President - Strategy and Corporate Development
Daveen Chopra
Corporate Vice President - Transcatheter Mitral and Tricuspid Therapies
Jean-Luc Lemercier
Corporate Vice President, EMEACLA (Europe, Middle East, Africa, Canada and Latin America)
Daniel Lippis
Corporate Vice President - JAPAC (Japan, Greater China and Asia Pacific)
Catherine M. Szyman
Corporate Vice President - Critical Care
Larry L. Wood
Corporate Vice President and Group President, Transcatheter Aortic Valve Replacement
Nicholas J. Valeriani
Independent Chairman of the Board
David T. Feinberg
Director
Kieran T. Gallahue
Independent Director
Leslie S. Heisz
Independent Director
Paul A. Laviolette
Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US28176E1082
  • Market cap
    $42.10bn
  • Employees
    19,800
  • Shares in issue
    654.30m
  • Exchange
    New York Stock Exchange
  • Index
    S&P 500, TR Equity United States Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.